Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Shares Outstanding (2016 - 2025)

Standard Biotools (LAB) has disclosed Shares Outstanding for 7 consecutive years, with $29.2 million as the latest value for Q4 2016.

  • On a quarterly basis, Shares Outstanding rose 1.26% to $29.2 million in Q4 2016 year-over-year; TTM through Dec 2016 was $29.2 million, a 1.26% increase, with the full-year FY2016 number at $29.2 million, up 1.26% from a year prior.
  • Shares Outstanding was $29.2 million for Q4 2016 at Standard Biotools, up from $28.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $29.2 million in Q4 2016 to a low of $25.1 million in Q4 2012.
  • A 5-year average of $27.5 million and a median of $28.3 million in 2014 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: rose 23.59% in 2012, then increased 1.26% in 2016.
  • Standard Biotools' Shares Outstanding stood at $25.1 million in 2012, then rose by 2.77% to $25.8 million in 2013, then rose by 9.8% to $28.3 million in 2014, then rose by 1.77% to $28.8 million in 2015, then increased by 1.26% to $29.2 million in 2016.
  • Per Business Quant, the three most recent readings for LAB's Shares Outstanding are $29.2 million (Q4 2016), $28.8 million (Q4 2015), and $28.3 million (Q4 2014).